Patents Assigned to Pericor Therapeutics, Inc.
  • Patent number: 9539274
    Abstract: The present invention provides methods, compositions, formulations, and kits related to acadesine, or a prodrug, analog, or salt thereof, and/or a blood clotting inhibitor for preventing or reducing adverse side effects in a patient. The type of patient that may benefit includes a patient with decreased left ventricular function, a patient with a prior myocardial infarction, a patient undergoing non-vascular surgery, or a fetus during labor and delivery.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: January 10, 2017
    Assignee: Pericor Therapeutics, Inc.
    Inventor: Dennis T. Mangano
  • Patent number: 9492468
    Abstract: The present disclosure provides methods and compositions for treating acute heart failure, by administering to a subject in need thereof a therapeutically effective amount of an AICA riboside analog or a pharmaceutically acceptable salt or prodrug thereof.
    Type: Grant
    Filed: October 2, 2009
    Date of Patent: November 15, 2016
    Assignee: PERICOR THERAPEUTICS, INC.
    Inventor: Richard R. Stover
  • Patent number: 8993527
    Abstract: The present invention provides methods, compositions, formulations, and kits related to acadesine, or a prodrug, analog, or salt thereof, and/or a blood clotting inhibitor for preventing or reducing adverse side effects in a patient. The type of patient that may benefit includes a patient with decreased left ventricular function, a patient with a prior myocardial infarction, a patient undergoing non-vascular surgery, or a fetus during labor and delivery.
    Type: Grant
    Filed: March 28, 2006
    Date of Patent: March 31, 2015
    Assignee: Pericor Therapeutics, Inc.
    Inventor: Dennis T. Mangano